17 February 2026
17 February 2026
As RLTs and theranostics gain prevalence, companies must consider how to overcome their associated regulatory, manufacturing and reimbursement hurdles.
Lilly’s amassing of a $1.5bn pre-launch inventory follows sizeable investments into US manufacturing facilities.
This verdict could spell the end for Translarna’s decades-long and tumultuous US DMD development journey.
Cordex plans to work with German transplant centres on individual NUB applications and expand clinical adoption.
The collaboration intends to improve compound screening by employing CADD and AI technologies.
The AURORA and BEACON studies demonstrated that bitopertin significantly reduces whole blood metal-free PPIX.
Merging industry-leading business intelligence & award-winning journalism, this is an unrivalled opportunity for engagement with B2B professionals across a network of 40+ leading media websites.
Steer your business strategy with key data and insights from our latest market research reports and company profiles. Not ready to buy? Start small by downloading a sample report first.
Give your business an edge with our leading industry insights.
